Target intelligence / Profile preview

Glycosylation-dependent cell adhesion molecule 1 (GLYCAM1)

Target
GLYCAM1
Molecular classification
Other (Mucin-like endothelial glycoprotein, proteoglycan ligand, cell adhesion molecule ligand)
01

Overview

Glycosylation-dependent cell adhesion molecule 1 (GLYCAM1) is a mucin-like proteoglycan ligand predominantly expressed on high endothelial venules in lymphoid tissues, where it presents O-linked carbohydrates that serve as ligands for L-selectin on leukocytes, facilitating the exit of naïve lymphocytes from the bloodstream into lymphoid organs. GLYCAM1 is also known to be hormonally regulated and expressed in mammary epithelial cells during lactation, where it is found in milk in a carbohydrate-modified form that does not bind L-selectin, suggesting tissue- and context-dependent biological roles. Functionally, GLYCAM1 mediates lymphocyte homing and trafficking and plays a regulatory role in monocyte entry into tissues such as the optic nerve head. It belongs to the class of mucin-like cell adhesion molecules but lacks a transmembrane region and appears as a soluble protein or, in some tissues, a milk mucin complex component. There are no drugs or therapeutic interventions known to target GLYCAM1 directly, and it is not currently employed as a clinical biomarker or druggable target.

Other names
Putative glycosylation-dependent cell adhesion molecule 1GLYCAM1GlyCAM-1Sgp50Sele ligand
02

Biological functions

Cell adhesionLeukocyte traffickingLigand for L-selectinRegulation of monocyte entryMilk protein (hormonally regulated)
03

Disease associations

Inflammation (role in lymphocyte and monocyte trafficking)Other (may contribute to immune function and potentially tissue-specific immune responses; limited direct disease association in humans)

Beyond the preview

Go deeper on Glycosylation-dependent cell adhesion molecule 1 (GLYCAM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosylation-dependent cell adhesion molecule 1 (GLYCAM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call